Updates are available Correction dated 2021-08-13

Article History

Received: 29 August 2019

Accepted: 25 October 2019

First Online: 13 November 2019

Change Date: 13 August 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1038/s41598-021-95732-x

Competing interests

: Dr. Lozano reports grants and personal fees from Amgen, personal fees from Novartis, grants and personal fees from Terumo S.A., personal fees from Macopharma, and personal fees from Grifols S.A., outside the submitted work. Dr. Mingot-Castellano reports grants and personal fees from Amgen, Novartis, Sobi, Novonordisk, Takeda, Bayer, Roche, CSL Behring outside the submitted work. Dr. Perera declares no competing interests. Dr. Jarque reports consulting honorarium from Amgen, Novartis, Shionogi. Dr. Campos-Alvarez reports speaker honorarium from Amgen, Novartis, outside the submitted work. Dr. Gonzalez-Lopez reports grants and personal fees from Novartis and Amgen, outside the submitted work. Dr. Carreño-Tarragona declares no competing interests. Dr. Bermejo declares no competing interests. Dr. López-Fernández reports advisory honorarium & speaker honorarium from Amgen, outside the submitted work. Dr. de Andres declares advisory honorarium from Amgen outside the submitted work. Dr. Valcarcel reports Advisory board member for Amgen, Novartis, Celgene, Pfizzer, JAZZ, Astellas, MSD; speaker honorarium from Amgen, Novartis, Celgene, Pfizzer, JAZZ, Astellas, MSD; advisory honorarium from Amgen, Novartis, Celgene, Pfizzer, JAZZ, Astellas, MSD; travel grants from Amgen, Novartis, Celgene, Pfizzer, JAZZ, Astellas, MSD, outside the submitted work. Dr. Casado-Montero reports speaker honorarium from Amgen and Novartis; advisory honorarium from Amgen and Novartis; advisory board member for Novartis, outside the submitted work. Dr. Alvarez-Roman reports consultant and speaker for Sobi, CSL Behring, Roche, Pfizer, Bayer, Novartis, and Amgen; research grants from Takeda, outside the submitted work. Dr. Orts declares no competing interests. Dr. Novelli declares no competing interests. Dr. Gonzalez-Porras reports fees for consulting services by Amgen, Novartis, SOBI, Grifols and CSL Behring, and speaking honoraria for Novonordisk, Shire, SOBI, Daiichi Sankyo, Pfizer, Rovi, Amgen, and Novartis, outside the submitted work. Dr. Bolaños declares no competing interests. Dr. Orna Montero reports speaker honorarium from Amgen, Novartis, outside the submitted work. Dr Revilla reports personal fees from Amgen outside the submitted work. Dr. Vicente reports advisory honorarium & speaker honorarium from Amgen, Novartis, Boehringer-Ingelheim, Pfizer, Bayer, and Daiichi Sankyo, outside the submitted work.